Literature DB >> 32761297

Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey.

Rachel Yelk Woodruff1, Andrew Hill2, Suzanne Marks2, Thomas Navin2, Roque Miramontes2.   

Abstract

Increased testing and treatment of latent tuberculosis infection (LTBI) among US-residents who were born (or lived) in countries with high rates of TB can hasten progress toward TB elimination. We calculated LTBI prevalence using QuantiFERON®-TB Gold In-Tube results from the 2011 to 2012 National Health and Nutrition Examination Survey (NHANES). LTBI prevalence was highest for persons born in India (31.7%, 95% confidence interval [21.2, 44.5]). Non-Hispanic white persons had the lowest LTBI prevalence (6.3% [1.9, 18.9]). TB reactivation rate, defined as the number of TB cases not associated with recent transmission per 100 person-years of life with LTBI, was highest for persons born in Vietnam [0.183 (0.117, 0.303)]. Reactivation rates were lower among persons who had resided in the United States for ≥ 10 years than among those who had resided for < 10 years. Results among high risk populations can guide LTBI targeted testing and treatment among non-U.S.-born residents.

Entities:  

Keywords:  LTBI; Latent tuberculosis infection; Non-U.S.-born; TB reactivation

Mesh:

Year:  2021        PMID: 32761297      PMCID: PMC7862421          DOI: 10.1007/s10903-020-01065-8

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  23 in total

1.  Changes in the transmission of tuberculosis in New York City from 1990 to 1999.

Authors:  Elvin Geng; Barry Kreiswirth; Cynthia Driver; Jiehui Li; Joseph Burzynski; Phyllis DellaLatta; Angel LaPaz; Neil W Schluger
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

2.  A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997.

Authors:  R M Jasmer; J A Hahn; P M Small; C L Daley; M A Behr; A R Moss; J M Creasman; G F Schecter; E A Paz; P C Hopewell
Journal:  Ann Intern Med       Date:  1999-06-15       Impact factor: 25.391

3.  Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas.

Authors:  Sourya Shrestha; Andrew N Hill; Suzanne M Marks; David W Dowdy
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

4.  The Prevalence of Latent Tuberculosis Infection in the United States.

Authors:  James D Mancuso; Jeffrey M Diffenderfer; Bijan J Ghassemieh; David J Horne; Tzu-Cheg Kao
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

5.  Modelling tuberculosis trends in the USA.

Authors:  A N Hill; J E Becerra; K G Castro
Journal:  Epidemiol Infect       Date:  2012-01-11       Impact factor: 2.451

6.  Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.

Authors:  Nicolas A Menzies; Ted Cohen; Andrew N Hill; Reza Yaesoubi; Kara Galer; Emory Wolf; Suzanne M Marks; Joshua A Salomon
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

7.  Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-09-08

Review 8.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

Authors:  Rein M G J Houben; Peter J Dodd
Journal:  PLoS Med       Date:  2016-10-25       Impact factor: 11.069

9.  Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015.

Authors:  Maryam B Haddad; Kala M Raz; Timothy L Lash; Andrew N Hill; J Steve Kammerer; Carla A Winston; Kenneth G Castro; Neel R Gandhi; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883

10.  US Tuberculosis Rates among Persons Born Outside the United States Compared with Rates in Their Countries of Birth, 2012-20161.

Authors:  Clarisse A Tsang; Adam J Langer; J Steve Kammerer; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.